TILs
tumor, tumors, TILs
CERVICAL CANCER, TUMORS, TUMOR
TIL therapy in cervical cancer has gained continuous attention over the past decade. After being separated from a host’s surgically removed tumors, TILs are then expanded ex vivo and reinfused into the host’s body without genetic modifications. These TILs are polyclonal, meaning that they can recognize a range of tumor antigens (LN-145 plus Pembrolizumab. LN-145 is a type of autologous TIL therapy (